These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12472903)

  • 1. Assembly of tau in transgenic animals expressing P301L tau: alteration of phosphorylation and solubility.
    Sahara N; Lewis J; DeTure M; McGowan E; Dickson DW; Hutton M; Yen SH
    J Neurochem; 2002 Dec; 83(6):1498-508. PubMed ID: 12472903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylated p38MAPK specific antibodies cross-react with sarkosyl-insoluble hyperphosphorylated tau proteins.
    Sahara N; Vega IE; Ishizawa T; Lewis J; McGowan E; Hutton M; Dickson D; Yen SH
    J Neurochem; 2004 Aug; 90(4):829-38. PubMed ID: 15287888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of TBS-extractable hyperphosphorylated tau species: aggregation intermediates in rTg4510 mouse brain.
    Sahara N; DeTure M; Ren Y; Ebrahim AS; Kang D; Knight J; Volbracht C; Pedersen JT; Dickson DW; Yen SH; Lewis J
    J Alzheimers Dis; 2013; 33(1):249-63. PubMed ID: 22941973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase in tau tyrosine phosphorylation correlates with the formation of tau aggregates.
    Vega IE; Cui L; Propst JA; Hutton ML; Lee G; Yen SH
    Brain Res Mol Brain Res; 2005 Aug; 138(2):135-44. PubMed ID: 15913839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice.
    Ishizawa T; Sahara N; Ishiguro K; Kersh J; McGowan E; Lewis J; Hutton M; Dickson DW; Yen SH
    Am J Pathol; 2003 Sep; 163(3):1057-67. PubMed ID: 12937146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein.
    Allen B; Ingram E; Takao M; Smith MJ; Jakes R; Virdee K; Yoshida H; Holzer M; Craxton M; Emson PC; Atzori C; Migheli A; Crowther RA; Ghetti B; Spillantini MG; Goedert M
    J Neurosci; 2002 Nov; 22(21):9340-51. PubMed ID: 12417659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Filamentous tau in oligodendrocytes and astrocytes of transgenic mice expressing the human tau isoform with the P301L mutation.
    Lin WL; Lewis J; Yen SH; Hutton M; Dickson DW
    Am J Pathol; 2003 Jan; 162(1):213-8. PubMed ID: 12507904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin-negative mini-pick-like bodies in the dentate gyrus in p301l tauopathy.
    Ferrer I; Hernández I; Puig B; Rey MJ; Ezquerra M; Tolosa E; Boada M
    J Alzheimers Dis; 2003 Dec; 5(6):445-54. PubMed ID: 14757934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary Lycopene Supplementation Improves Cognitive Performances in Tau Transgenic Mice Expressing P301L Mutation via Inhibiting Oxidative Stress and Tau Hyperphosphorylation.
    Yu L; Wang W; Pang W; Xiao Z; Jiang Y; Hong Y
    J Alzheimers Dis; 2017; 57(2):475-482. PubMed ID: 28269786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PE859, a novel tau aggregation inhibitor, reduces aggregated tau and prevents onset and progression of neural dysfunction in vivo.
    Okuda M; Hijikuro I; Fujita Y; Wu X; Nakayama S; Sakata Y; Noguchi Y; Ogo M; Akasofu S; Ito Y; Soeda Y; Tsuchiya N; Tanaka N; Takahashi T; Sugimoto H
    PLoS One; 2015; 10(2):e0117511. PubMed ID: 25659102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a double (amyloid precursor protein-tau) transgenic: tau phosphorylation and aggregation.
    Pérez M; Ribe E; Rubio A; Lim F; Morán MA; Ramos PG; Ferrer I; Isla MT; Avila J
    Neuroscience; 2005; 130(2):339-47. PubMed ID: 15664690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regenerating islet-derived 1α (REG-1α) protein increases tau phosphorylation in cell and animal models of tauopathies.
    Moussaed M; Huc-Brandt S; Cubedo N; Silhol M; Murat S; Lebart MC; Kovacs G; Verdier JM; Trousse F; Rossel M; Marcilhac A
    Neurobiol Dis; 2018 Nov; 119():136-148. PubMed ID: 30092268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF phospho-tau correlates with behavioural decline and brain insoluble phospho-tau levels in a rat model of tauopathy.
    Zilka N; Korenova M; Kovacech B; Iqbal K; Novak M
    Acta Neuropathol; 2010 Jun; 119(6):679-87. PubMed ID: 20379729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern of tau hyperphosphorylation and neurotransmitter markers in the brainstem of senescent tau filament forming transgenic mice.
    Morcinek K; Köhler C; Götz J; Schröder H
    Brain Res; 2013 Feb; 1497():73-84. PubMed ID: 23261664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau protein is cross-linked by transglutaminase in P301L tau transgenic mice.
    Halverson RA; Lewis J; Frausto S; Hutton M; Muma NA
    J Neurosci; 2005 Feb; 25(5):1226-33. PubMed ID: 15689560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous tau aggregates in oligodendrocytes of rTg4510 mice induced by human P301L tau.
    Ren Y; Lin WL; Sanchez L; Ceballos C; Polydoro M; Spires-Jones TL; Hyman BT; Dickson DW; Sahara N
    J Alzheimers Dis; 2014; 38(3):589-600. PubMed ID: 24028867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrastructural neuronal pathology in transgenic mice expressing mutant (P301L) human tau.
    Lin WL; Lewis J; Yen SH; Hutton M; Dickson DW
    J Neurocytol; 2003 Nov; 32(9):1091-105. PubMed ID: 15044841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated neurodegeneration and neuroinflammation in transgenic mice expressing P301L tau mutant and tau-tubulin kinase 1.
    Asai H; Ikezu S; Woodbury ME; Yonemoto GM; Cui L; Ikezu T
    Am J Pathol; 2014 Mar; 184(3):808-18. PubMed ID: 24418258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active glycogen synthase kinase-3 and tau pathology-related tyrosine phosphorylation in pR5 human tau transgenic mice.
    Köhler C; Dinekov M; Götz J
    Neurobiol Aging; 2013 May; 34(5):1369-79. PubMed ID: 23294633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. V363I and V363A mutated tau affect aggregation and neuronal dysfunction differently in C. elegans.
    Morelli F; Romeo M; Barzago MM; Bolis M; Mattioni D; Rossi G; Tagliavini F; Bastone A; Salmona M; Diomede L
    Neurobiol Dis; 2018 Sep; 117():226-234. PubMed ID: 29936232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.